Letter: Skin reactions to practolol.
作者信息
Wright P
出版信息
Br Med J. 1974 Jun 8;2(5918):560. doi: 10.1136/bmj.2.5918.560.
Abstract
摘要
相似文献
1
Letter: Skin reactions to practolol.信函：心得宁引起的皮肤反应。
Br Med J. 1974 Jun 8;2(5918):560. doi: 10.1136/bmj.2.5918.560.
2
Letter: Report on adverse reactions associated with practolol.信函：关于心得宁相关不良反应的报告。
Med J Aust. 1974 Nov 16;2(20):758.
3
[Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].[实际的迟发效应。心得宁（埃拉洛尔）治疗期间的皮肤、眼睛和听力变化]
Ugeskr Laeger. 1975 Apr 28;137(18):1016-7.
4
Eye and skin reactions precede practolol peritonitis.眼部和皮肤反应先于心得宁性腹膜炎出现。
Lancet. 1977;2(8052-8053):1354. doi: 10.1016/s0140-6736(77)90397-x.
5
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.对心得宁代谢产物具有特异性的抗体在眼黏膜皮肤综合征发病机制中的可能作用。
Br Med J. 1978 Feb 18;1(6110):402-4. doi: 10.1136/bmj.1.6110.402.
6
Letter: Skin reactions to practolol.信件：心得宁引起的皮肤反应。
Br Med J. 1974 May 11;2(5914):333. doi: 10.1136/bmj.2.5914.333-c.
7
[Adverse effects of practolol].
Duodecim. 1976;92(22):1264-5.
8
Adverse effects of practolol.
Ann Clin Res. 1976 Aug;8(4):229-31.
9
Practolol and the safety of other beta blockers.心得宁与其他β受体阻滞剂的安全性
N Z Med J. 1976 Oct 13;84(573):282-5.
10
Cutaneous reactions to practolol. Clinical and histopathological study.心得宁的皮肤反应。临床与组织病理学研究。
Ann Clin Res. 1976 Aug;8(4):232-40.
引用本文的文献
1
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity.随着时间的推移，向监管机构自发报告 COVID-19 疫苗疑似药物不良反应：宣传的效果。
Drug Saf. 2022 Feb;45(2):137-144. doi: 10.1007/s40264-021-01138-z. Epub 2022 Jan 22.
2
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.发表药品不良反应病例报告的重要性：促进公众健康并推动药理学与治疗学发展
Drug Saf Case Rep. 2017 Sep 20;4(1):11. doi: 10.1007/s40800-017-0053-0.
3
Reports of adverse drug reactions in general medical journals.
Ir J Med Sci. 1982 Jun;151(6):184-7. doi: 10.1007/BF02940176.
4
Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?新药不良反应的识别。II——18种重要不良反应是如何被发现的，以及延迟了多久？
Br Med J (Clin Res Ed). 1983 Jan 22;286(6361):289-92. doi: 10.1136/bmj.286.6361.289.
5
Rare and serious adverse reactions.
Med Toxicol Adverse Drug Exp. 1987 Jul-Aug;2(4):235-41. doi: 10.1007/BF03259867.
6
Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics.醋丁洛尔（ Sectral ）和心得宁（ Eraldin ）对哮喘患者气道阻塞影响的比较。
Br J Clin Pharmacol. 1975 Oct;2(5):417-22. doi: 10.1111/j.1365-2125.1975.tb00550.x.
7
President's address. Problems of communication of the medicines division of the DHSS.主席致辞。卫生与社会保障部药品司的沟通问题。
Proc R Soc Med. 1977 Dec;70(12):835-9. doi: 10.1177/003591577707001203.
8
Ocular reaction to timolol maleate.对马来酸噻吗洛尔的眼部反应。
Postgrad Med J. 1979 Dec;55(654):884-5. doi: 10.1136/pgmj.55.650.884.
9
Detection of drug-induced disease.药物性疾病的检测
Br J Clin Pharmacol. 1979 Jan;7(1):13-8. doi: 10.1111/j.1365-2125.1979.tb00890.x.
10
Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.阿替洛尔（氨酰心安，帝国化学工业公司产品）的降眼压作用。一种新型β-肾上腺素能阻滞剂。
Br J Ophthalmol. 1975 Jun;59(6):296-300. doi: 10.1136/bjo.59.6.296.
Zotero 插件